SKC podcast

#01 with Prof. Dr. Hagen Pfundner, CEO of Roche Pharma AG

Tue, 2022 / 05 / 31
In the first edition of our SKC podcast, Prof. Dr. Hagen Pfundner, CEO of Roche Pharma AG, is our guest. Prof. Matthias P. Schönermark, M.D., Ph.D. and he speak about scientific and technological leaps in rare diseases, unusual paths of orphan drugs at the pharmaceutical giant Roche, why orphanization is a dirty word and which potentials molecular genetic diagnostics hold.

You can find the SKC podcast Profcast #01 Geniale Mutausbrüche in German language on Spotify and Apple Podcast. Listen now!

The Profcast - Rare diseases and their therapies

Our SKC podcast series "The Profcast - rare diseases and their therapies" aims to address the special circumstances of patients with rare diseases, the associated medicine and the challenges for research, development, economics and reimbursement. For this purpose, Prof. Matthias P. Schönermark, M.D., Ph.D., managing director of SKC, speaks with patient representatives, payers, clinicians and scientists as well as industry representatives and also focuses on specific diseases. The word Profcast is a reference to professionals or professors, whom he welcomes as his guests.

The ambition behind this is to give an appropriate space to rare diseases and their treatment sine ira et studio. After all, the motto of the Rare Disease Day states it so aptly: "Rare is many". It is estimated that 4 million people in Germany and 300 million people worldwide are affected by a rare disease. In keeping with the Rare Disease Day, which traditionally takes place on the last day of February, the Profcast will always be published on the last day of a month.

About the author

Ihr Ansprechpartner Prof. Matthias P. Schönermark, M.D., Ph.D.
Prof. Matthias P. Schönermark, M.D., Ph.D.
Founder and Managing Director
Fon: +49 511 64 68 14 0 – 0
Fax: +49 511 64 68 14 18
to the top